We’re improving your experience!

×

Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.

Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.

Stay tuned for these updates, and thank you for being part of our community!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02847559
Title Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Northwestern University
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
John Wayne Cancer Center at Providence St. John's Health Center COMPLETED Santa Monica California 90404 United States Details
Miami Cancer Institute COMPLETED Miami Florida 33176 United States Details
Piedmont Healthcare COMPLETED Atlanta Georgia 30309 United States Details
Northwestern University RECRUITING Chicago Illinois 60611 United States Details
Northwestern University- Lake Forest Hospital ACTIVE_NOT_RECRUITING Lake Forest Illinois 60045 United States Details
Northwestern Medicine/ Cadence Health - CDH RECRUITING Winfield Illinois 60190 United States Details
Vidant Medical Center, East Caroling University ACTIVE_NOT_RECRUITING Greenville North Carolina 27834 United States Details
University of Pennsylvania RECRUITING Philadelphia Pennsylvania 19104 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field